Dylan Aïssi

Dylan Aïssi

Auto-generated profile, based on publicly available information

Dylan Aïssi

Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in The Lancet
Verified
Journal Article
Closed access
KDKatherine J Dick
Katherine J Dick
CNChristopher Nelson
Christopher Nelson
LTLoukia Tsaprouni
Loukia Tsaprouni
JSJohanna K Sandling
Johanna K Sandling
DADylan Aïssi
Dylan Aïssi
NSNilesh J Samani
Nilesh J Samani

6 September 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JMJosine L. Min
Josine L. Min
GHGibran Hemani
Gibran Hemani
EHEilis Hannon
Eilis Hannon
KDKoen F. Dekkers
Koen F. Dekkers
JCJuan Castillo-Fernandez
Juan Castillo-Fernandez
CRCaroline L. Relton
Caroline L. Relton

1 April 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MGMarine Germain
Marine Germain
DCDaniel I. Chasman
Daniel I. Chasman
HHHugoline de Haan
Hugoline de Haan
WTWeihong Tang
Weihong Tang
SLSara Lindström
Sara Lindström
PMPierre-Emmanuel Morange
Pierre-Emmanuel Morange

26 February 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMathieu Lemire
Mathieu Lemire
SZSyed H.E. Zaidi
Syed H.E. Zaidi
MBMaria Ban
Maria Ban
BGBing Ge
Bing Ge
DADylan Aïssi
Dylan Aïssi
THThomas J. Hudson
Thomas J. Hudson
The interplay between genetic and epigenetic variation is only partially understood. One form of epigenetic variation is methylation at CpG sites, which can be measured as methylation quantitative trait loci (meQTL). Here we report that in a panel of lymphocytes from 1,748 individuals, methylation levels at 1,919 CpG sites are correlated with at least one distal (trans) single-nucleotide polymorphism (SNP) (P<3.2 × 10−13; FDR1 Mb apart. Over 90% of these pairs are replicated (FDR<5%) in at least one of two independent data sets. Genomic loci harbouringtrans-meQTLs are significantly enriched (P<0.001) for long non-coding transcripts (2.2-fold), known epigenetic regulators (2.3-fold), piwi-interacting RNA clusters (3.6-fold) and curated transcription factors (4.1-fold), including zinc-finger proteins (8.75-fold). Long-range epigenetic networks uncovered by this approach may be relevant to normal and disease states.

18 October 2022 in Circulation
Verified
Journal Article
Closed access
PDF file
FTFlorian Thibord
Florian Thibord
DKDerek Klarin
Derek Klarin
JBJennifer A. Brody
Jennifer A. Brody
MCMing-Huei Chen
Ming-Huei Chen
MLMichael G. Levin
Michael G. Levin
NSNicholas L. Smith
Nicholas L. Smith
Background: Venous thromboembolism (VTE) is a life-threatening vascular event with environmental and genetic determinants. Recent VTE genome-wide association studies (GWAS) meta-analyses involved nearly 30 000 VTE cases and identified up to 40 genetic loci associated with VTE risk, including loci not previously suspected to play a role in hemostasis. The aim of our research was to expand discovery of new genetic loci associated with VTE by using cross-ancestry genomic resources. Methods: We present new cross-ancestry meta-analyzed GWAS results involving up to 81 669 VTE cases from 30 studies, with replication of novel loci in independent populations and loci characterization through in silico genomic interrogations. Results: In our genetic discovery effort that included 55 330 participants with VTE (47 822 European, 6320 African, and 1188 Hispanic ancestry), we identified 48 novel associations, of which 34 were replicated after correction for multiple testing. In our combined discovery-replication analysis (81 669 VTE participants) and ancestry-stratified meta-analyses (European, African, and Hispanic), we identified another 44 novel associations, which are new candidate VTE-associated loci requiring replication. In total, across all GWAS meta-analyses, we identified 135 independent genomic loci significantly associated with VTE risk. A genetic risk score of the significantly associated loci in Europeans identified a 6-fold increase in risk for those in the top 1% of scores compared with those with average scores. We also identified 31 novel transcript associations in transcriptome-wide association studies and 8 novel candidate genes with protein quantitative-trait locus Mendelian randomization analyses. In silico interrogations of hemostasis and hematology traits and a large phenome-wide association analysis of the 135 GWAS loci provided insights to biological pathways contributing to VTE, with some loci contributing to VTE through well-characterized coagulation pathways and others providing new data on the role of hematology traits, particularly platelet function. Many of the replicated loci are outside of known or currently hypothesized pathways to thrombosis. Conclusions: Our cross-ancestry GWAS meta-analyses identified new loci associated with VTE. These findings highlight new pathways to thrombosis and provide novel molecules that may be useful in the development of improved antithrombosis treatments.

10 March 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
WCWarren Cheung
Warren Cheung
XSXiaojian Shao
Xiaojian Shao
AMAndréanne Morin
Andréanne Morin
VSValérie Siroux
Valérie Siroux
TKTony Kwan
Tony Kwan
EGElin Grundberg
Elin Grundberg
The functional impact of genetic variation has been extensively surveyed, revealing that genetic changes correlated to phenotypes lie mostly in non-coding genomic regions. Studies have linked allele-specific genetic changes to gene expression, DNA methylation, and histone marks but these investigations have only been carried out in a limited set of samples. We describe a large-scale coordinated study of allelic and non-allelic effects on DNA methylation, histone mark deposition, and gene expression, detecting the interrelations between epigenetic and functional features at unprecedented resolution. We use information from whole genome and targeted bisulfite sequencing from 910 samples to perform genotype-dependent analyses of allele-specific methylation (ASM) and non-allelic methylation (mQTL). In addition, we introduce a novel genotype-independent test to detect methylation imbalance between chromosomes. Of the ~2.2 million CpGs tested for ASM, mQTL, and genotype-independent effects, we identify ~32% as being genetically regulated (ASM or mQTL) and ~14% as being putatively epigenetically regulated. We also show that epigenetically driven effects are strongly enriched in repressed regions and near transcription start sites, whereas the genetically regulated CpGs are enriched in enhancers. Known imprinted regions are enriched among epigenetically regulated loci, but we also observe several novel genomic regions (e.g., HOX genes) as being epigenetically regulated. Finally, we use our ASM datasets for functional interpretation of disease-associated loci and show the advantage of utilizing naïve T cells for understanding autoimmune diseases. Our rich catalogue of haploid methylomes across multiple tissues will allow validation of epigenome association studies and exploration of new biological models for allelic exclusion in the human genome.